NCT00915993: MRI in Predicting Response to Sunitinib Malate in Patients With Stage IV Kidney Cancer |
|
|
| Recruiting | N/A | 40 | US | sunitinib malate, mutation analysis, immunohistochemistry staining method, laboratory biomarker analysis, pharmacological study, dynamic contrast-enhanced magnetic resonance imaging | University of Pennsylvania, National Cancer Institute (NCI) | Kidney Cancer | 05/11 | | | |
NCT02186925: A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney. |
|
|
| Recruiting | N/A | 1000 | RoW | | Meir Medical Center | Kidney Cancer, Prostate Cancer, Bladder Cancer | 08/19 | 08/25 | | |